You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Trophoblast cell surface antigen

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced/ Metastatic Solid Tumors Trial in Shanghai (FDA018-ADC)

Recruiting
  • Advanced/ Metastatic Solid Tumors
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 14, 2021

Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Cryoablation
  • Cryoablation combined with PD1 Inhibitor
  • (no location specified)
Mar 28, 2023

Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

Recruiting
  • DLBCL
  • +8 more
  • Cardiac MRI
  • Bonn, NRW, Germany
    University Hospital Bonn
Jun 11, 2022

Identify Barriers to Cellular Therapies for People With Plasma

Recruiting
  • Multiple Myeloma
  • Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
  • +5 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 6, 2023

Digestive Tumor Trial (TM4SF1-positive chimeric antigen receptor T-cell therapy)

Not yet recruiting
  • Digestive Tumor
  • TM4SF1-positive chimeric antigen receptor T-cell therapy
  • (no location specified)
Dec 21, 2022

Subfertility Trial in Hong Kong (endometrial biopsy)

Completed
  • Subfertility
  • endometrial biopsy
  • Hong Kong, Hong Kong, China
    Department of Obstetrics and Gynaecology
Mar 2, 2022

HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

Active, not recruiting
  • HIV-1-infection
  • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam University Medical Centers, location AMC
Jan 31, 2023

Peripheral T Cell Lymphoma Trial in China (CAR-T Therapy)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • CAR-T Therapy
  • Hefei, Anhui, China
  • +7 more
Jul 31, 2023

Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

Active, not recruiting
  • Hepatitis B
  • Baltimore, Maryland
  • +9 more
Jan 17, 2023

Hepatitis B Trial in Worldwide (JNJ-56136379, Placebo, NA (ETV or TDF))

Completed
Has Results
  • Hepatitis B
  • Bakersfield, California
  • +75 more
Oct 24, 2022

Melanoma Trial in New York (Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs))

Completed
  • Melanoma
  • Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 12, 2023

Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,

Recruiting
  • Refractory Multiple Myeloma
  • Relapsed Multiple Myeloma
  • Manufactured Anti-BCMA CAR-T cells
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and

Not yet recruiting
  • Multiple Sclerosis
  • Neurofilament Light Chain ,Chitinase-3 Like-1 Protein Levels and Tolerogenic plasmacytoid Dendritic Cells
  • (no location specified)
Oct 10, 2022

Positron Emission Radiomics With PSMA Radioligands on Newly

Not yet recruiting
  • Prostate Cancer
  • Immunohistochemistry (IHC) analysis
  • (no location specified)
Apr 6, 2023

Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

Recruiting
  • Lupus Nephritis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Denver, Colorado
  • +1 more
Jul 7, 2023

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Palo Alto, California
    Stanford Multiple Sclerosis Center
Nov 13, 2023

Lymphoma, Lymphoma Cns Trial in Boston (Fludarabine, Cyclophosphamide, Axicabtagene Ciloleucel)

Recruiting
  • Lymphoma
  • Lymphoma Cns
  • Boston, Massachusetts
  • +1 more
Jan 3, 2023

Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)

Recruiting
  • Leukemia
  • Lymphoma
  • SCRI-CAR22v2
  • Los Angeles, California
  • +4 more
Jan 18, 2023

Chronic Aspergillus Infection After COVID-19 Infection

Recruiting
  • Aspergillosis
  • This is a blood test without regarding to intervention nor diagnostic tests
  • Taipei, Taiwan
    Shiang Fen Huang
Nov 12, 2023

CAR, Acute Myeloid Leukemia Trial in Hefei (TAA05 cell injection)

Recruiting
  • CAR
  • Acute Myeloid Leukemia
  • TAA05 cell injection
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Nov 3, 2021

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 30, 2022

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Locally Advanced or Metastatic Solid Tumors Trial in Shanghai (Anti-5T4 CAR-raNK Cells)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • Anti-5T4 CAR-raNK Cells
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Oct 25, 2022